Daniel Javitt - Nov 11, 2022 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
10%+ Owner
Signature
Daniel Javitt
Stock symbol
NRXP
Transactions as of
Nov 11, 2022
Transactions value $
-$49,510
Form type
4
Date filed
11/15/2022, 06:40 PM
Previous filing
Aug 2, 2022
Next filing
Nov 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXP common stock Sale -$49.5K -49.2K -0.5% $1.01 9.82M Nov 11, 2022 by Glytech LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022.
F2 Held by Glytech LLC of which the Reporting Person is the sole owner.